135 related articles for article (PubMed ID: 8301103)
21. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans.
Eisenhofer G; Brush JE; Cannon RO; Stull R; Kopin IJ; Goldstein DS
J Clin Endocrinol Metab; 1989 Feb; 68(2):247-55. PubMed ID: 2563731
[TBL] [Abstract][Full Text] [Related]
22. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
[TBL] [Abstract][Full Text] [Related]
23. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.
Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD
Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093
[TBL] [Abstract][Full Text] [Related]
24. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine.
Eisenhofer G; Esler MD; Meredith IT; Dart A; Cannon RO; Quyyumi AA; Lambert G; Chin J; Jennings GL; Goldstein DS
Circulation; 1992 May; 85(5):1775-85. PubMed ID: 1572033
[TBL] [Abstract][Full Text] [Related]
25. Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder.
Esler M; Alvarenga M; Barton D; Jennings G; Kaye D; Guo L; Schwarz R; Lambert G
Front Psychiatry; 2022; 13():818012. PubMed ID: 35722546
[TBL] [Abstract][Full Text] [Related]
26. Dihydroxyphenylalanine and dopamine are released from portal vein together with noradrenaline and dihydroxyphenylglycol during nerve stimulation.
Hunter LW; Rorie DK; Tyce GM
J Neurochem; 1992 Sep; 59(3):972-82. PubMed ID: 1494920
[TBL] [Abstract][Full Text] [Related]
27. Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses.
Esler M
Pharmacol Toxicol; 1993 Nov; 73(5):243-53. PubMed ID: 8115306
[TBL] [Abstract][Full Text] [Related]
28. Noradrenaline synthesis, release and vesicular transport in the rat brain following subarachnoid haemorrhage.
Lambert E; Hastings J; Lambert G
Brain Res Bull; 2001 Jul; 55(4):459-63. PubMed ID: 11543944
[TBL] [Abstract][Full Text] [Related]
29. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
Atuk NO; Hanks JB; Weltman J; Bogdonoff DL; Boyd DG; Vance ML
J Clin Endocrinol Metab; 1994 Dec; 79(6):1609-14. PubMed ID: 7989464
[TBL] [Abstract][Full Text] [Related]
30. Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits.
Eisenhofer G; Cox HS; Esler MD
J Auton Nerv Syst; 1991 Mar; 32(3):217-31. PubMed ID: 2037769
[TBL] [Abstract][Full Text] [Related]
31. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors.
Esler MD; Thompson JM; Kaye DM; Turner AG; Jennings GL; Cox HS; Lambert GW; Seals DR
Circulation; 1995 Jan; 91(2):351-8. PubMed ID: 7805237
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of elevated plasma noradrenaline in the course of essential hypertension.
Esler M; Jennings G; Biviano B; Lambert G; Hasking G
J Cardiovasc Pharmacol; 1986; 8 Suppl 5():S39-43. PubMed ID: 2427882
[TBL] [Abstract][Full Text] [Related]
33. Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.
Eisenhofer G; Cox HS; Esler MD
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):328-35. PubMed ID: 2280799
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system noradrenergic and dopaminergic turnover in response to acute neuroleptic challenge.
Lambert GW; Horne M; Kalff V; Kelly MJ; Turner AG; Cox HS; Jennings GL; Esler MD
Life Sci; 1995; 56(19):1545-55. PubMed ID: 7723582
[TBL] [Abstract][Full Text] [Related]
35. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man.
Mörlin C; Wallin BG; Eriksson BM
Acta Physiol Scand; 1983; 119(2):117-21. PubMed ID: 6659984
[TBL] [Abstract][Full Text] [Related]
36. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.
Brunner-La Rocca HP; Esler MD; Jennings GL; Kaye DM
Eur Heart J; 2001 Jul; 22(13):1136-43. PubMed ID: 11428854
[TBL] [Abstract][Full Text] [Related]
37. Neuronal re-uptake of noradrenaline by sympathetic nerves in humans.
Eisenhofer G; Esler MD; Meredith IT; Ferrier C; Lambert G; Jennings G
Clin Sci (Lond); 1991 Mar; 80(3):257-63. PubMed ID: 1850686
[TBL] [Abstract][Full Text] [Related]
38. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension.
Rumantir MS; Jennings GL; Lambert GW; Kaye DM; Seals DR; Esler MD
J Hypertens; 2000 Jun; 18(6):717-23. PubMed ID: 10872556
[TBL] [Abstract][Full Text] [Related]
39. Increased cardiac sympathetic drive in renovascular hypertension.
Petersson MJ; Rundqvist B; Johansson M; Eisenhofer G; Lambert G; Herlitz H; Jensen G; Friberg P
J Hypertens; 2002 Jun; 20(6):1181-7. PubMed ID: 12023689
[TBL] [Abstract][Full Text] [Related]
40. Cardiac noradrenergic function one year following cardiac transplantation.
Rundquist B; Eisenhofer G; Dakak NA; Elam M; Waagstein F; Friberg P
Blood Press; 1993 Dec; 2(4):252-61. PubMed ID: 8173693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
